1.9106
price up icon0.56%   0.0106
 
loading
전일 마감가:
$1.90
열려 있는:
$1.91
하루 거래량:
642
Relative Volume:
0.09
시가총액:
$10.89M
수익:
$2.35M
순이익/손실:
$-2.56M
주가수익비율:
-4.3462
EPS:
-0.4396
순현금흐름:
-
1주 성능:
-3.77%
1개월 성능:
+0.21%
6개월 성능:
-21.05%
1년 성능:
+1.90%
1일 변동 폭
Value
$1.91
$2.00
1주일 범위
Value
$1.89
$2.0848
52주 변동 폭
Value
$1.59
$5.96

이뮤론 Stock (IMRN) Company Profile

Name
명칭
Immuron Limited Adr
Name
전화
-
Name
주소
-
Name
직원
7
Name
트위터
@ImmuronLtd
Name
다음 수익 날짜
2024-08-27
Name
최신 SEC 제출 서류
Name
IMRN's Discussions on Twitter

IMRN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IMRN
Immuron Limited Adr
1.9106 10.89M 2.35M -2.56M 0 -0.4481
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
401.84 103.35B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
703.15 77.35B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
621.19 37.04B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
236.07 30.14B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
112.54 26.97B 3.30B -501.07M 1.03B -2.1146

이뮤론 주식(IMRN)의 최신 뉴스

pulisher
Nov 21, 2024

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event - GlobeNewswire Inc.

Nov 21, 2024
pulisher
Nov 18, 2024

Immuron to Present at Q4 Virtual Investor Summit: Gut Disease Pipeline Showcase | IMRN Stock News - StockTitan

Nov 18, 2024
pulisher
Oct 15, 2024

Immuron Travelan® continued strong sales growth - Quantisnow

Oct 15, 2024
pulisher
Oct 04, 2024

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study - The Manila Times

Oct 04, 2024
pulisher
Sep 12, 2024

IMRNImmuron Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Sep 12, 2024
pulisher
Sep 06, 2024

Immuron: US FDA provides favourable feedback ahead of investigational new drug application for IMM-529 - Proactive Investors Australia

Sep 06, 2024
pulisher
Sep 05, 2024

Immuron Plans Phase 2 Trial for IMM-529 following FDA review - Markets Insider

Sep 05, 2024
pulisher
Sep 05, 2024

Immuron Plans Phase 2 Trial for IMM-529 following FDA review | Daily Guardian - Daily Guardian Canada

Sep 05, 2024
pulisher
Aug 16, 2024

Immuron secures new US DoD research award - Investing.com

Aug 16, 2024
pulisher
Aug 16, 2024

Immuron secures new US DoD research award By Investing.com - Investing.com Australia

Aug 16, 2024
pulisher
Jul 17, 2024

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire Inc.

Jul 17, 2024
pulisher
Jul 15, 2024

Treasuries slip, dollar firm as markets grapple with US politics By Reuters - Investing.com

Jul 15, 2024
pulisher
Jul 05, 2024

Curtiss Wright CEO Lynn M Bamford buys $10.2k in stock By Investing.com - Investing.com India

Jul 05, 2024
pulisher
Jul 05, 2024

Immuron CEO to present at Sharewise investor event By Investing.com - Investing.com

Jul 05, 2024
pulisher
Jul 03, 2024

Immuron to raise up to $2M as part of an ATM equity offering (NASDAQ:IMRN) - Seeking Alpha

Jul 03, 2024
pulisher
Jul 02, 2024

Immuron secures around US$2 million in funding after lodging Form F-3 and ATM prospectus with US SEC By ... - Investing.com

Jul 02, 2024
pulisher
Jul 02, 2024

Immuron requests pre-IND meeting for IMM-529 with FDA filing - Markets Insider

Jul 02, 2024
pulisher
Jul 01, 2024

Immuron files pre-investigational new drug US FDA application for superbug fighting IMM-529 - Proactive Investors Australia

Jul 01, 2024
pulisher
Jun 25, 2024

Immuron Surges On U.S. DoD Funding For Travelan Research - Yahoo Movies UK

Jun 25, 2024
pulisher
Apr 10, 2024

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Markets Insider

Apr 10, 2024
pulisher
Mar 08, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34% - Investing.com India

Mar 08, 2024
pulisher
Mar 07, 2024

Immuron stock surges after mid-stage data for Travelan - Seeking Alpha

Mar 07, 2024
pulisher
May 16, 2023

Immuron Limited Announces Participation in the LD Micro Invitational XIII - The Kingston Whig-Standard

May 16, 2023
pulisher
Jan 25, 2023

Immuron US DoD Naval Medical Research Center responds to - GlobeNewswire

Jan 25, 2023
pulisher
Feb 03, 2020

Immuron’s Technology Platform of Treatments in the Age of the Coronavirus Outbreak - GlobeNewswire

Feb 03, 2020
pulisher
Jun 27, 2018

Immuron Limited Trade Ideas — NASDAQ:IMRN - TradingView

Jun 27, 2018
pulisher
Mar 08, 2018

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.33% - Investing.com

Mar 08, 2018
pulisher
Mar 07, 2018

Immuron Limited Issues Correction to Misleading Halt Announcement Headline - GlobeNewswire

Mar 07, 2018
pulisher
Jan 31, 2016

Pharma & Biotech - Proactive Investors USA

Jan 31, 2016

이뮤론 (IMRN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$68.46
price down icon 1.17%
$20.80
price down icon 1.07%
$38.96
price down icon 2.72%
$355.76
price down icon 1.11%
$181.94
price down icon 0.21%
$112.40
price down icon 1.39%
자본화:     |  볼륨(24시간):